Cargando…

FIP1L1-PDGFRα p.T674I-D842L: A Novel and Ponatinib Resistant Compound Mutation in FIP1L1-PDGFRα Positive Leukemia

Detalles Bibliográficos
Autores principales: Lierman, Els, Smits, Sanne, Appleby, Niamh, Conneally, Eibhlin, Michaux, Lucienne, Vandenberghe, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746033/
https://www.ncbi.nlm.nih.gov/pubmed/31723821
http://dx.doi.org/10.1097/HS9.0000000000000182
_version_ 1783451644078325760
author Lierman, Els
Smits, Sanne
Appleby, Niamh
Conneally, Eibhlin
Michaux, Lucienne
Vandenberghe, Peter
author_facet Lierman, Els
Smits, Sanne
Appleby, Niamh
Conneally, Eibhlin
Michaux, Lucienne
Vandenberghe, Peter
author_sort Lierman, Els
collection PubMed
description
format Online
Article
Text
id pubmed-6746033
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-67460332019-11-13 FIP1L1-PDGFRα p.T674I-D842L: A Novel and Ponatinib Resistant Compound Mutation in FIP1L1-PDGFRα Positive Leukemia Lierman, Els Smits, Sanne Appleby, Niamh Conneally, Eibhlin Michaux, Lucienne Vandenberghe, Peter Hemasphere Letter Wolters Kluwer Health 2019-02-22 /pmc/articles/PMC6746033/ /pubmed/31723821 http://dx.doi.org/10.1097/HS9.0000000000000182 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle Letter
Lierman, Els
Smits, Sanne
Appleby, Niamh
Conneally, Eibhlin
Michaux, Lucienne
Vandenberghe, Peter
FIP1L1-PDGFRα p.T674I-D842L: A Novel and Ponatinib Resistant Compound Mutation in FIP1L1-PDGFRα Positive Leukemia
title FIP1L1-PDGFRα p.T674I-D842L: A Novel and Ponatinib Resistant Compound Mutation in FIP1L1-PDGFRα Positive Leukemia
title_full FIP1L1-PDGFRα p.T674I-D842L: A Novel and Ponatinib Resistant Compound Mutation in FIP1L1-PDGFRα Positive Leukemia
title_fullStr FIP1L1-PDGFRα p.T674I-D842L: A Novel and Ponatinib Resistant Compound Mutation in FIP1L1-PDGFRα Positive Leukemia
title_full_unstemmed FIP1L1-PDGFRα p.T674I-D842L: A Novel and Ponatinib Resistant Compound Mutation in FIP1L1-PDGFRα Positive Leukemia
title_short FIP1L1-PDGFRα p.T674I-D842L: A Novel and Ponatinib Resistant Compound Mutation in FIP1L1-PDGFRα Positive Leukemia
title_sort fip1l1-pdgfrα p.t674i-d842l: a novel and ponatinib resistant compound mutation in fip1l1-pdgfrα positive leukemia
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746033/
https://www.ncbi.nlm.nih.gov/pubmed/31723821
http://dx.doi.org/10.1097/HS9.0000000000000182
work_keys_str_mv AT liermanels fip1l1pdgfrapt674id842lanovelandponatinibresistantcompoundmutationinfip1l1pdgfrapositiveleukemia
AT smitssanne fip1l1pdgfrapt674id842lanovelandponatinibresistantcompoundmutationinfip1l1pdgfrapositiveleukemia
AT applebyniamh fip1l1pdgfrapt674id842lanovelandponatinibresistantcompoundmutationinfip1l1pdgfrapositiveleukemia
AT conneallyeibhlin fip1l1pdgfrapt674id842lanovelandponatinibresistantcompoundmutationinfip1l1pdgfrapositiveleukemia
AT michauxlucienne fip1l1pdgfrapt674id842lanovelandponatinibresistantcompoundmutationinfip1l1pdgfrapositiveleukemia
AT vandenberghepeter fip1l1pdgfrapt674id842lanovelandponatinibresistantcompoundmutationinfip1l1pdgfrapositiveleukemia